Jian Min Fang
Chief Executive Officer en REMEGEN CO., LTD. .
Fortuna: 84 M $ al 31/03/2024
Perfil
Jian Min Fang fundó RemeGen Co., Ltd. y MabPlex International Ltd. El Dr. Fang ocupa el cargo de presidente de MabPlex International Ltd. y de director general, director ejecutivo y director científico de RemeGen Co. El Dr. Fang también forma parte del consejo de la Asociación Farmacéutica China, Remegen Medical Research Shanghai Co. Ltd., Remegen Biosciences, Inc. y Remegen Hong Kong Ltd. y Vicepresidente de la División de Medicamentos Anticuerpos de la Asociación de Biotecnología Médica de China. El Dr. Fang se doctoró en la Universidad de Dalhousie.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REMEGEN CO. LTD. CLASS H
12.79% | 01/10/2023 | 24 244 500 ( 12.79% ) | 84 M $ | 31/03/2024 |
Cargos activos de Jian Min Fang
| Empresas | Cargo | Inicio |
|---|---|---|
| REMEGEN CO., LTD. | Chief Executive Officer | 04/07/2008 |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Founder | 25/06/2013 |
| Remegen Medical Research Shanghai Co. Ltd. | Director/Board Member | - |
| Remegen Biosciences, Inc. | Director/Board Member | - |
| Remegen Hong Kong Ltd. | Director/Board Member | - |
| Chinese Pharmaceutical Association | Director/Board Member | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - |
Formación de Jian Min Fang.
| Dalhousie University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REMEGEN CO., LTD. | Health Technology |
| Empresas privadas | 6 |
|---|---|
| Chinese Pharmaceutical Association | |
| China Medicinal Biotech Association | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Remegen Medical Research Shanghai Co. Ltd. | |
| Remegen Biosciences, Inc. | |
| Remegen Hong Kong Ltd. |
- Bolsa de valores
- Insiders
- Jian Min Fang
